Short-Term Bullish Options Activity in Therapix Biosciences (TRPX) -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Barclays Starts TRONOX (TROX) at Overweight, Regulatory Risk Offset By Valuation and Potential Synergies
December 14, 2017 3:25 AM ESTBarclays initiates coverage on TRONOX (NYSE: TROX) with a Overweight rating and a price target of $25.00.
Analyst Duffy Fischer says the company is likely to be the largest TiO2 operators if the Cristal TiO2 acquisition is consummated and if TiO2 strength remains that... More



